Alisa Ellison
Primary Care · Hinton, WVNPI 1578806105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 108 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$374
- AbbVie$370
- Lilly USA, LLC$289
- Novo Nordisk$198
- GSK$102
- Astellas Pharma US Inc$85
- plus $614 from 16 others
What the payments were for
- Food & beverage$1,94296%
- Education$914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $374 |
| AbbVie | 18 | $370 |
| Lilly USA, LLC | 18 | $289 |
| Novo Nordisk | 11 | $198 |
| GSK | 6 | $102 |
| Astellas Pharma US Inc | 1 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $80 |
| Averitas Pharma Inc. | 3 | $72 |
| Amgen | 4 | $61 |
| Abbott | 3 | $58 |
| Dexcom, Inc. | 3 | $58 |
| Novartis | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Pfizer | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
How this compares
$2,032 in reported general payments places this provider in the 75th percentile of 43 primary care providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 113 | $119,606 |
| EliquisApixaban | 91 | $88,001 |
| MounjaroTirzepatide | 69 | $78,603 |
| FarxigaDapagliflozin Propanediol | 88 | $78,379 |
| OzempicSemaglutide | 47 | $72,140 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 53 | $42,026 |
| XareltoRivaroxaban | 27 | $33,569 |
| JardianceEmpagliflozin | 33 | $31,421 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $31,165 |
| EntrestoSacubitril/Valsartan | 17 | $23,385 |
| VraylarCariprazine Hcl | 12 | $17,868 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $16,579 |
| BelbucaBuprenorphine Hcl | 22 | $15,351 |
| JanuviaSitagliptin Phosphate | 16 | $14,683 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $14,050 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $289 | $198,208182 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $374 | $94,958114 claims |
| PfizerEliquis | $32 | $88,00191 claims |
| Novo NordiskOzempic | $198 | $72,14047 claims |
| GSKTrelegy Ellipta | $102 | $42,02653 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $13 | $38,33448 claims |
| AbbVieVraylar, Linzess | $370 | $26,89524 claims |
| NovartisEntresto | $36 | $23,38517 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 43 primary care providers in West Virginia.
Other primary care in Hinton
- Amanda WakimWheeling$169K
- Brenda HashemBerkeley Springs$8K
- Brenda DennisGlen Dale$6K
- Molly WhiteCharleston$5K
- Richard SutherlandMartinsburg$4K
- Kayla MeadeHuntington$3K
- Crystal Clark-CrookshanksSummersville$3K
- Jessica FrankeGlen Dale$2K
- Jerica BoboRomney$2K
- Amber BellMorgantown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.